China Procedure Numbers for Gynecological Devices
The full report suite on the China market for gynecological devices includes assisted reproduction technology, endometrial resection, uterine fibroid embolization, hysteroscopes, colposcopes, female urinary incontinence slings, pelvic organ prolapse as well as discussions on the emerging markets of laser technology and dyspareunia treatments and fluid management equipment.
- EXECUTIVE SUMMARY
- CHINA MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW
- COMPETITIVE ANALYSIS
- MARKET TRENDS
- MARKET DEVELOPMENTS
- MARKETS INCLUDED
- KEY REPORT UPDATES
- VERSION HISTORY
- RESEARCH METHODOLOGY
- 1.1 RESEARCH SCOPE
- 1.2 IDATA’S 9-STEP METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- DISEASE OVERVIEW
- 2.1 BASIC ANATOMY
- 2.2 DISEASE PATHOLOGY AND DISORDERS
- 2.2.1 Introduction
- 2.2.2 General Diagnostics
- 2.2.3 Indications for Assisted Reproduction Technologies (ART)
- 2.2.3.1 ART cost: coverage policy and medical insurance in different countries
- 2.2.4 Abnormal Uterine Bleeding
- 2.2.5 Gynecologic Cancer and Tumors in Reproductive System
- 2.2.6 Indications for Female Sterilization
- 2.2.7 Urinary Incontinence
- 2.2.8 Indications for Pelvic Organ Prolapse Repair
- 2.2.9 Indications for CO2 Fractional Laser
- PROCEDURE NUMBERS
- 3.1 PROCEDURE ANALYSIS AND FORECAST
- 3.1.1 Introduction
- 3.1.2 Assisted Reproduction Procedures
- 3.1.3 Uterine Fibroid Embolization Procedures
- 3.1.4 Female Urinary Incontinence Sling Procedures
- 3.1.5 Pelvic Organ Prolapse Procedures
- 3.1.5.1 Trans-Vaginal Mesh Procedures
- 3.1.5.2 Sacrocolpopexy Procedures
- 3.2 CHINA NATIONAL HEALTHCARE STATISTICS
- 3.3 HS-9 CODES FOR GYNECOLOGY CAPITAL EQUIPMENT
- ABBREVIATIONS
- APPENDIX: COMPANY PRESS RELEASES
- List of Charts
- Chart 1 1: Gynecological Device Market by Segment, China, 2013 – 2023
- Chart 1 2: Gynecological Device Market by Segment, China, 2016 & 2023
- List of Figures
- Figure 1 1: Gynecological Device Market by Segment, China, 2016 (1 of 2)
- Figure 1 2: Gynecological Device Market by Segment, China, 2016 (2 of 2)
- Figure 1 3: Companies Researched in this Report, China, 2016
- Figure 1 4: Factors Impacting the Gynecological Device Market by Segment, China (1 of 2)
- Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, China (2 of 2)
- Figure 1 6: Recent Events in the Gynecological Device Market, China, 2013 – 2016
- Figure 1 7: Gynecological Device Markets Covered, China, 2016
- Figure 1 8: Key Report Updates
- Figure 1 9: Version History
- Figure 2 1: Gynecological Disease Overview
- Figure 2 2: ART Procedure Availability Overview
- Figure 2 3: ART Procedure Availability Overview
- Figure 3 1: Assisted Reproduction Procedures, China, 2013 – 2023
- Figure 3 2: Total Uterine Fibroid Embolization Procedures, China, 2013 – 2023
- Figure 3 3: Female Urinary Incontinence Sling Procedures, China, 2013 – 2023
- Figure 3 4: Pelvic Organ Prolapse Procedures, China, 2013 – 2023
- Figure 3 5: Trans-Vaginal Mesh Procedures, China, 2013 – 2023
- Figure 3 6: Sacrocolpopexy Procedures, China, 2013 – 2023
- Figure 3 7: Number and Percentage of Doctors by Department, Mainland China
- Figure 3 8: Percentage of Outpatients by Department in General Hospitals, Mainland China
- Figure 3 9: Total Health Expenditures, Mainland China
- Figure 3 10: Number of Health Institutions, Mainland China
- Figure 3 11: Import and Export Commodities (HS-9 Codes) in Quantity and Value, 2014
- Figure 5 1: Press Release Summary